Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections
Revisado por: David Aguilera Alonso
Grupo de trabajo: Infecciones relacionadas con la asistencia sanitaria
Referencia: F Morrisette T, Stimes GT, Alvira-Arill GR, et al. Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections. Open Forum Infect Dis. 2026 Apr 20;13(4):ofag177. doi: 10.1093/ofid/ofag177
Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial
Revisado por: María Belén Hernández Rupérez
Grupo de trabajo: Infecciones de manejo ambulatorio
Referencia: Boralevi F, Simon G, Bernigaud C, et al. Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial. BMJ. 2026 Jan 6;392:e086277. doi: 10.1136/bmj-2025-086277.
A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trial
Revisado por: Manuel Vargas Pérez
Grupo de trabajo: Infecciones de manejo ambulatorio
Referencia: Verbakel JY, Burvenich R, D’hulster E, et al. A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trial. Lancet. 2025; 406: 1599-610
Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns.
Revisado por: Cristina Calvo
Grupo de trabajo: Infecciones Respiratorias
Referencia: Jabagi MJ, et al. Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns. JAMA. 2025 Dec 22:e2524082. doi: 10.1001/jama.2025.24082. Epub ahead of print. PMID: 41428474; PMCID: PMC12723599.
A comparative study of urine dipstick testing with urine culture in pediatric urinary tract infection (0–5 years): a cross-sectional observational study
Revisado por: Marta Cruz Cañete
Grupo de trabajo: Infecciones de manejo ambulatorio
Referencia: Muthusamy S, Raju PN, et al. A comparative study of urine dipstick testing with urine culture in pediatric urinary tract infection (0–5 years): a cross-sectional observational study. Pediatr Infect Dis. 2025;7(4):118–124. doi:10.5005/jp-journals-10081-1486.
OPTIPAC study group. Impact of respiratory pathogens detection by a rapid multiplex polymerase chain reaction assay on the management of community-acquired pneumonia for children at the paediatric emergency department. A randomized controlled trial, the Optimization of Pneumonia Acute Care (OPTIPAC) study
Revisado por: Marta Cruz-Cañete
Grupo de trabajo: Infecciones Respiratorias
Referencia: Cantais A, et al. OPTIPAC study group. Impact of respiratory pathogens detection by a rapid multiplex polymerase chain reaction assay on the management of community-acquired pneumonia for children at the paediatric emergency department. A randomized controlled trial, the Optimization of Pneumonia Acute Care (OPTIPAC) study. Clin Microbiol Infect. 2025;31:64-70.
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study.
Revisado por: Alfredo Tagarro
Grupo de trabajo: Infecciones Respiratorias
Referencia: Razzini JL, Giné-Vázquez I, Jin J, et al. Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study. Lancet Infect Dis. 2026 Jan 12:S1473-3099(25)00742-X. doi: 10.1016/S1473-3099(25)00742-X.
Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis
Revisado por: Laura Francisco González
Grupo de trabajo: Infecciones Respiratorias
Referencia: Arrieta AC, Osborne S, Grant LR, et al. Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis. Pediatr Infect Dis J. 2025 Apr 21;44(7):622-629. doi: 10.1097/INF.0000000000004833.
